Paris - Delayed Quote EUR
Virbac SA (VIRP.PA)
305.40
+2.05
+(0.68%)
At close: April 24 at 5:35:27 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 6 |
| Avg. Estimate | 0 | 0 | 19.23 | 21.16 |
| Low Estimate | 0 | 0 | 18.83 | 20.46 |
| High Estimate | 0 | 0 | 19.91 | 22.45 |
| Year Ago EPS | -- | -- | 18.21 | 19.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 7 |
| Avg. Estimate | -- | -- | 1.48B | 1.55B |
| Low Estimate | -- | -- | 1.47B | 1.52B |
| High Estimate | -- | -- | 1.5B | 1.58B |
| Year Ago Sales | -- | -- | 1.4B | 1.48B |
| Sales Growth (year/est) | -- | -- | 5.87% | 5.03% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 19.23 | 21.16 |
| 7 Days Ago | 0 | 0 | 19.47 | 21.39 |
| 30 Days Ago | 0 | 0 | 19.69 | 21.58 |
| 60 Days Ago | 0 | 0 | 19.42 | 21.55 |
| 90 Days Ago | 0 | 0 | 19.83 | 22.05 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 3 | 3 |
| Down Last 30 Days | -- | -- | 2 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VIRP.PA | -- | -- | 5.63% | 9.99% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Upgrade | Kepler Cheuvreux: Hold to Buy | 7/19/2021 |
Related Tickers
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
AMGN.MX Amgen Inc.
5,500.00
0.00%
4AB.F AbbVie Inc.
155.80
0.00%
OPHLY Ono Pharmaceutical Co., Ltd.
3.8600
-1.03%
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.98
+3.10%
ORNBVh.XC
NOV.MU Novo Nordisk A/S
55.01
+1.05%
GRF-P.MC Grifols SA
6.41
+0.16%
0R34.IL Johnson & Johnson
155.60
-1.46%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,830.00
-2.97%